{"id":"https://openalex.org/W4409688913","doi":"https://doi.org/10.1158/1538-7445.am2025-1858","title":"Abstract 1858: Nanoformulation strategy for oral delivery of KRAS inhibitor (sotorasib): pH-independent dissolution to mitigate PPI drug interaction","display_name":"Abstract 1858: Nanoformulation strategy for oral delivery of KRAS inhibitor (sotorasib): pH-independent dissolution to mitigate PPI drug interaction","publication_year":2025,"publication_date":"2025-04-21","ids":{"openalex":"https://openalex.org/W4409688913","doi":"https://doi.org/10.1158/1538-7445.am2025-1858"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2025-1858","doi":"https://doi.org/10.1158/1538-7445.am2025-1858","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2025-1858","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068543567","display_name":"Henis J. Patel","orcid":"https://orcid.org/0000-0002-1908-0683","observed_orcids":["https://orcid.org/0000-0002-1908-0683"]},"institutions":[{"id":"https://openalex.org/I142823887","display_name":"St. John's University","ror":"https://ror.org/00bgtad15","country_code":"US","type":"education","lineage":["https://openalex.org/I142823887"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Henis Patel","raw_affiliation_strings":["St. John's University, Queens, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. John's University, Queens, NY","institution_ids":["https://openalex.org/I142823887"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038006474","display_name":"Akanksha Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I142823887","display_name":"St. John's University","ror":"https://ror.org/00bgtad15","country_code":"US","type":"education","lineage":["https://openalex.org/I142823887"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Akanksha Patel","raw_affiliation_strings":["St. John's University, Queens, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. John's University, Queens, NY","institution_ids":["https://openalex.org/I142823887"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073989904","display_name":"Ketan R. Patel","orcid":"https://orcid.org/0000-0001-8252-0234","observed_orcids":["https://orcid.org/0000-0001-8252-0234"]},"institutions":[{"id":"https://openalex.org/I142823887","display_name":"St. John's University","ror":"https://ror.org/00bgtad15","country_code":"US","type":"education","lineage":["https://openalex.org/I142823887"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ketan Patel","raw_affiliation_strings":["St. John's University, Queens, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St. John's University, Queens, NY","institution_ids":["https://openalex.org/I142823887"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I142823887"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"85","issue":"8_Supplement_1","first_page":"1858","last_page":"1858"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sotorasib","display_name":"sotorasib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/kras-g12c-inhibitors","display_name":"KRAS G12C inhibitors","score":0.949999988079071},{"id":"https://openalex.org/keywords/oral-drug-delivery","display_name":"oral drug delivery","score":0.6769999861717224},{"id":"https://openalex.org/keywords/nanoparticle-suspensions","display_name":"nanoparticle suspensions","score":0.8109999895095825},{"id":"https://openalex.org/keywords/proton-pump-inhibitors","display_name":"proton pump inhibitors","score":0.9079999923706055},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.5619999766349792},{"id":"https://openalex.org/keywords/bioavailability","display_name":"bioavailability","score":0.7400000095367432},{"id":"https://openalex.org/keywords/wet-media-milling","display_name":"wet media milling","score":0.9020000100135803},{"id":"https://openalex.org/keywords/hydroxypropyl-beta-cyclodextrin","display_name":"hydroxypropyl-\u03b2-cyclodextrin","score":0.9520000219345093},{"id":"https://openalex.org/keywords/trehalose","display_name":"trehalose","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cryoprotectants","display_name":"cryoprotectants","score":0.8510000109672546},{"id":"https://openalex.org/keywords/redispersibility","display_name":"redispersibility","score":0.7829999923706055},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8899999856948853},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8270000219345093},{"id":"https://openalex.org/keywords/weakly-basic-drugs","display_name":"weakly basic drugs","score":0.6399999856948853}],"concepts":[{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6506382822990417},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5906895399093628},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4725893437862396},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.45306286215782166},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4004397690296173},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2025-1858","doi":"https://doi.org/10.1158/1538-7445.am2025-1858","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2025-1858","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4387497383","https://openalex.org/W2948807893","https://openalex.org/W2899084033","https://openalex.org/W2778153218","https://openalex.org/W2748952813","https://openalex.org/W1531601525","https://openalex.org/W4391375266","https://openalex.org/W3031052312","https://openalex.org/W4389568370","https://openalex.org/W3032375762"],"abstract_inverted_index":{"Abstract":[0],"Biovariability":[1],"poses":[2],"a":[3,26,37,88,99,123,138,276,312],"significant":[4,277],"challenge":[5],"in":[6,56,69,153,162,246,268,279],"the":[7,74,214,234,247,251,293,299,351],"oral":[8,334],"administration":[9],"of":[10,76,301,336,350],"sotorasib":[11],"(AMG":[12],"510),":[13],"an":[14,229],"FDA-approved":[15],"KRAS":[16,337],"G12C":[17],"inhibitor":[18,338],"for":[19,233,319,333,354],"non-small":[20],"cell":[21],"lung":[22,320],"cancer":[23,70,321],"(NSCLC).":[24],"Sotorasib,":[25],"weakly":[27,77],"basic":[28,78],"drug":[29,125,180,262,306,345],"with":[30,64,102,129,275,308],"limited":[31],"aqueous":[32],"and":[33,51,60,107,117,137,149,168,192,211,220,253,260,285,305],"pH-dependent":[34],"solubility,":[35],"necessitates":[36],"high":[38,47,124,302],"daily":[39],"dose":[40],"(960":[41],"mg;":[42],"8":[43],"tablets).":[44],"In":[45,173,264],"general,":[46],"doses,":[48],"pill":[49],"burdens,":[50],"poor":[52,57],"solubility":[53,259],"often":[54],"result":[55],"patient":[58],"compliance":[59],"therapeutic":[61,317],"outcomes.":[62],"Co-administration":[63],"proton":[65],"pump":[66],"inhibitors":[67],"(PPIs)":[68],"patients":[71],"significantly":[72],"reduces":[73],"bioavailability":[75],"drugs":[79],"including":[80,199],"sotorasib.":[81],"To":[82],"address":[83,298],"these":[84],"limitations,":[85],"we":[86],"developed":[87],"pH-independent":[89,340],"nanocrystalline":[90],"formulation":[91,101],"through":[92],"wet":[93],"media":[94],"milling,":[95],"aiming":[96],"to":[97,256,292,315,342],"achieve":[98],"stable":[100],"enhanced":[103,238],"bioavailability,":[104],"improved":[105,221,257],"redispersibility,":[106],"minimized":[108,261],"fasted/fed":[109],"variability.":[110],"The":[111,240],"nanosuspension,":[112,236],"formulated":[113],"using":[114],"anionic":[115],"surfactant":[116],"non-ionic":[118],"polymer":[119],"as":[120],"stabilizers,":[121],"achieved":[122],"load":[126],"(45%":[127],"w/w)":[128],"uniformly":[130],"distributed":[131],"nanocrystals":[132],"(173":[133],"\u00b1":[134,143,282,288],"21.54":[135],"nm)":[136],"negative":[139],"zeta":[140],"potential":[141],"(-36.0":[142],"0.57":[144],"mV).":[145],"Cryoprotectants":[146],"hydroxypropyl-\u03b2-cyclodextrin":[147],"(HP\u03b2-CD)":[148],"trehalose":[150],"were":[151],"effective":[152],"preventing":[154],"aggregation,":[155],"ensuring":[156],"excellent":[157],"redispersibility":[158],"across":[159],"pH":[160,187],"conditions":[161],"both":[163,186],"simulated":[164],"gastric":[165],"(pH":[166,170],"4.0)":[167],"intestinal":[169,248],"6.8)":[171],"environments.":[172],"vitro":[174],"dissolution":[175,191,341],"studies":[176,267],"demonstrated":[177],">":[178],"95%":[179],"release":[181],"within":[182],"5":[183],"minutes":[184],"at":[185],"levels,":[188],"indicating":[189],"rapid":[190],"robust":[193],"stability.":[194],"Solid":[195],"State":[196],"Characterization":[197],"studies,":[198],"X-ray":[200],"diffraction":[201],"(XRPD),":[202],"differential":[203],"scanning":[204,207],"calorimetry":[205],"(DSC),":[206],"electron":[208],"microscopy":[209],"(SEM),":[210],"cryo-TEM,":[212],"confirmed":[213],"preserved":[215],"crystallinity,":[216],"reduced":[217],"particle":[218],"size,":[219],"homogeneity.":[222],"Additionally,":[223],"BET":[224],"surface":[225,231],"area":[226,232],"analysis":[227],"indicated":[228],"increased":[230,244],"lyophilized":[235],"supporting":[237],"dissolution.":[239],"in-silico":[241],"model":[242],"predicted":[243],"absorption":[245],"region,":[249],"particularly":[250],"duodenum":[252],"jejunum":[254],"due":[255],"saturation":[258],"precipitation.":[263],"vivo":[265],"pharmacokinetic":[266],"SD":[269],"rats":[270],"revealed":[271],"superior":[272],"systemic":[273],"exposure,":[274],"increase":[278],"Cmax":[280],"(3529":[281],"564.57":[283],"ng/mL)":[284],"AUClast":[286],"(8294.5":[287],"1346.66":[289],"h*ng/mL)":[290],"compared":[291],"physical":[294],"mixture.":[295],"It":[296],"may":[297],"challenges":[300],"dosing":[303],"requirements":[304],"interactions":[307],"acid-reducing":[309],"agents,":[310],"offering":[311],"promising":[313],"solution":[314],"enhance":[316],"outcomes":[318],"patients.":[322],"Citation":[323],"Format:":[324],"Henis":[325],"Patel,":[326,328],"Akanksha":[327],"Ketan":[329],"Patel.":[330],"Nanoformulation":[331],"strategy":[332],"delivery":[335],"(sotorasib):":[339],"mitigate":[343],"PPI":[344],"interaction":[346],"[abstract].":[347],"In:":[348],"Proceedings":[349],"American":[352],"Association":[353],"Cancer":[355,372],"Research":[356],"Annual":[357],"Meeting":[358],"2025;":[359],"Part":[360],"1":[361],"(Regular":[362],"Abstracts);":[363],"2025":[364],"Apr":[365],"25-30;":[366],"Chicago,":[367],"IL.":[368],"Philadelphia":[369],"(PA):":[370],"AACR;":[371],"Res":[373],"2025;85(8_Suppl_1):Abstract":[374],"nr":[375],"1858.":[376]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}